New Matter: Inside the Minds of SLAS Scientists

In this first podcast of our series on new technologies, we welcomed back Iscaffpharma by chatting with Per Setterberg, CEO and  Professor Göran Landberg, CMO.  Göran talks to us about how pre-clinical testing in human tumor microenvironment  and synthetic copies of the same adds value to drug screening of oncology drugs. The model creates a pre-clinical fingerprint that mimics the potential effec...

This fun podcast is a mix of recording from SLAS2022 on site excitement, and some follow up with some of the winners afterwards. Tune in to hear from the following award winners: Student Poster Award Winners Antra Ganguly, PhD Student,  University of Texas At Dallas for A novel, non-culture based electrochemical sensor for multiplexed biomarker quantification towards rapid Urinary Tract Infection...

In this first episode with our new host, SLAS Scientific Manager, Hannah Rosen, we talk to Steven Graves , CEO and Founder at BennuBio, Inc about their new, high-throughput, multiple parallel stream system for flow cytometry.  Steve shares their biggest challenges in developing this technology and their goal in getting it out into commercial world  where it can do the most good. Listen in to find...

Today Vicki sits in as host and talks with Mike Tarselli, Chief Scientific Officer and Bill Hobbib, Chief Marketing Officer from TetraScience on the importance of being pragmatic and continuing to advance science through in person collaboration.  Nothing replaces the serendipity of meeting in person, and they discuss the importance of pushing out of our pandemic comfort levels and making new habit...

David Weinkove , CEO of Magnitude Biosciences joins us to talk to us about their work with C. elegans - tiny worms used to test compounds for health. We learn about the difference between a lifespan and a healthspan and how using these tiny worms to study the effects of compounds on aging is helpful.  David shares Magnitude's work as a CRO and how they translate their work into an industrial...

Are you interested in neuroscience? Have you ever thought about how the immune system talks to the brain? Want to learn about dissecting functions of brain circuitry? Today is your chance! We are joined by Dr. Randy Blakely from Florida Atlantic University Brain Institute who walks us through all the really cool work the Brain Institute focuses on, such as: the developing brain, brain behavior, he...

What does 30 years of providing innovative bioanalytical technology solutions look like? Oksana Sirenko , Ph. D., Senior Scientist at Molecular Devices , can tell you all about it. She shares the cool collaborations they have been involved with in biologics , high-content imaging , stem cell technologies , and automation . Click below to learn more about the technologies, research, and discoveries...

Today we get to hear about what experts in pharmaceutical technologies are doing in nanotechnology. We chat about the difference  between lipophilic delivery and drug delivery. Victor Francis from DIVERSA gives us a really solid breakdown of the differences and what DIVERSA does with different types of  drugs and their work with companies in the early stages of drug discovery. DIVERSA is going to...

Colleen Janczak from Scintillation Nanotechnologies talked with us today about the really neat work they are doing to make nano-material detectors for radio isotopes. Their vision is to bring previously unheard-of measurement capabilities to radioisotope detection, enabling researchers across the full range of scientific endeavors to ask and answer previously impossible research questions. This ep...

Julio Martin , SLAS European Ambassador, joins us again to co-host as we talk to Winston Chiu. Winston is an amazing young scientists who is a PhD student at KU Keuven in Belgium. Winston walks us through his research into highly infectious diseases, his adventures in robotic programming (and the accidents that happened along the way), and his viewpoint on life and learning.    Winston was a poste...

Today we hear Lillie Bell , who is studying BSc Medical Biochemistry at the University of Leeds .  Lillie in particular has been looking at target and protein degradation as she was recently she was a Undergraduate Industrial Placement Student in the highthrouput screening group at AstraZeneca .  She is really excited that some of the work she did while AstraZeneca will be used for novel chemistry...

Today we are chatting with members of the AI Powered Drug Discovery Symposium planning committee; Fernanda Duarte and Kurt Anderson . We are really excited about this hybrid symposium coming up in early November in London. The event has a really amazing line up of speakers as we explore the latest research on data-driven discovery. In addition to the traditional topics surrounding AI Powered Drug...

How do we combine physics and engineering with biomedical research to develop technological solutions for accelerating the human disease knowledge? What cool new technologies are there to discover these solutions to improve the quality of patient life? Well,  Silvia Scaglione from React4Life joins us today to share their deeply innovative and highly reactive work. Dive in with us today to find out...

Start By Listening. Sound advice from Amel Bendali of start-up Inorevia . She, and her fellow Co-founder, listened to what scientists in the field needed and decided to take the next step in lab automation by miniaturizing their processes. Hear how Inorevia is making things smaller, faster, and smarter  as Amel Bendali talks with SLAS Program Manager Liz Frank, and co-host Julio Martin on the late...

Is it possible for the body's own immune system to fight of cancer? It could be. This is what Stephan Spangenberg and his colleagues at Scripps Research Institute are trying to figure out. Colin Cox from Seer sits in today as co-host with Liz as they chat with Stephan about the ins and outs of his research, his student poster award win, and his excitement over publishing his first research pa...

Working in 3D systems can be challenging, and the presentations at the upcoming Building Biology in 3D Symposium will provide researchers with a swiss army knife of tools to improve their work.  Listen in  as members of the program committee share their excitement around the sessions, keynotes, and collaborative potential.  A special thanks to Brinton Seashore-Ludlow , Sinead Knight , Herve Tiriac...

Manuela Beil-Peter (Analytik Jena GmbH) and Clive Green (AstraZeneca) sit down with Liz to share how the program of the European Sample Management (ESM) Symposium will explore this mature discipline and the evolutions and advancements that have taken place in the last few years.  Listen in to find out how we plan to energize the community and prove that the future is bright!  The European Sample M...

A meta-roboticist, a theoretical physical inorganic chemist, and an automated science educator sit down for a podcast.... Join us today as guest host Mike Tarselli talks with Jason Hein, Joshua Schrier, and Josh Kangas  about the AI automation explosion. Where have we come from and where are we now? Where are we going and what are we doing to placate our pending robot overlords?  Let's find o...

How does cancer develop, grow, and how can we treat it? Where are we at in developing personalized cancer treatments? These the questions Pilar Ayuda-Durán has been trying to answer in her research into unraveling cancer biology and designing new treatments against the disease. Our guest host, Brinton Seashore-Ludlow gets a sneak peek into Pilar's current research and her excitement over the...

Members of the Americas Sample Management Symposium   Program Committee joined us today to talk about the importance of this small but strong community and their excitement over the symposium in just a few weeks. Listen in as the ladies share with us why it is so important this community gathers together this fall, what sessions they are most excited about, and what the icing on the cake at the sy...

Why are 3D cell cultures so exciting? What IS the difference between a 2D and 3D cell culture? Experts from Corning ;  Audrey Bergeron , Claire (Linyu) Zhang, and Alejandro Montoya joined Marshall to explain the new applications of 3D cell cultures and what considerations need to be taken into account when working within these new models. If you are looking to transition to using 3D cell cultures,...

Steve Swioklo visits New Matter this week to share with us how Atelerix technology provides an innovative solution for storing and transporting cells and tissues at room temperature and in a balanced state.  Steve also gives good advice on the transition between academia and a startup. Join us in learning more about this  Innovation Ave NEW company and where they want to go next.   Upcoming Events...

Join Ross Lagoy   and Marshall discussing CRISPR/Cas9 genome editing, developing critical platform technologies that accelerate drug discovery and how to connect the bench to automation. Ross is a Senior Scientist at Intellia Therapeutics working to establishing new technologies and analysis pipelines to help identify potential cures for patients living with genetic disease. Upcoming Events: SLAS...

On this episode we discuss the importance of bio convergence and how CELLINK Is looking at all the areas that lead to greater discovery in biology. Paul Berning shares with us their excitement at the development of an automation system designed to minimize labor-intensive processes and maximize efficiency within cell line development. As so many companies have, CELLINK had to pivot their work with...

Continuing on with the discussion on drug resistance in cancer treatment Ming Yao joins Marshall to share the tissue culture device that he helped to develop to better study drug response to tumor cells.  With an engineering background, when Ming started his graduate degree he had to take a crash course in biology and cell culture, which caused him to fall in love with science. Future researchers,...